RILZABRUTINIB

RILZABRUTINIB was reported 564 times

RILZABRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYCOPLASMA GENITALIUM INFECTION 1 0.0526
1 EAR DRYNESS 1 0.0095
2 EPENDYMOMA 1 0.0069
3 HEPATITIS B ANTIBODY POSITIVE 1 0.0053
4 SCHWANNOMA 1 0.0050
5 VIRAL SINUSITIS 1 0.0047
6 SUPERIOR MESENTERIC ARTERY SYNDROME 1 0.0045
7 GALLBLADDER ENLARGEMENT 4 0.0037
8 VOCAL CORD INFLAMMATION 1 0.0034
9 PLATELET COUNT ABNORMAL 20 0.0033
10 BILIARY OBSTRUCTION 4 0.0031
11 GASTRIC MUCOSA ERYTHEMA 1 0.0030
12 CATARACT OPERATION COMPLICATION 1 0.0020
13 INJURY CORNEAL 1 0.0019
14 PERFUME SENSITIVITY 1 0.0018
15 PLATELET COUNT 1 0.0017
16 SPLENECTOMY 2 0.0017
17 IMMUNE THROMBOCYTOPENIA 7 0.0015
18 CORNEAL DEPOSITS 1 0.0013
19 PLATELET COUNT DECREASED 143 0.0013
20 OESOPHAGEAL OBSTRUCTION 1 0.0012
21 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
22 CHOLECYSTITIS INFECTIVE 3 0.0011
23 BONE SWELLING 1 0.0010
24 BLOOD IRON ABNORMAL 1 0.0010
25 MOUTH HAEMORRHAGE 7 0.0010
26 PROSTATIC DISORDER 5 0.0009
27 BLADDER OPERATION 1 0.0009
28 CARDIAC PACEMAKER INSERTION 5 0.0008
29 EMBOLISM ARTERIAL 1 0.0008
30 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
31 FRACTURED COCCYX 1 0.0008
32 INCISIONAL HERNIA 1 0.0007
33 PETECHIAE 7 0.0007
34 FOOD INTERACTION 1 0.0006
35 SMALL INTESTINAL PERFORATION 1 0.0005
36 RADIOTHERAPY 1 0.0005
37 FUNGAL SKIN INFECTION 2 0.0005
38 HAEMATOLOGICAL INFECTION 1 0.0004
39 PLATELET DISORDER 1 0.0004
40 ENDODONTIC PROCEDURE 1 0.0004
41 INCREASED BRONCHIAL SECRETION 1 0.0004
42 URINE OUTPUT INCREASED 1 0.0004
43 RADICULOPATHY 1 0.0004
44 THERAPEUTIC RESPONSE DELAYED 1 0.0004
45 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
46 BACTERAEMIA 4 0.0003
47 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
48 FOREIGN BODY IN THROAT 1 0.0003
49 POLYMYALGIA RHEUMATICA 1 0.0003
50 LIVER ABSCESS 1 0.0003
51 EAR PRURITUS 1 0.0003
52 ERYTHEMA NODOSUM 1 0.0003
53 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
54 THROMBOCYTOSIS 1 0.0003
55 PRODUCT STORAGE ISSUE 1 0.0003
56 VITAMIN B12 DEFICIENCY 1 0.0002
57 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
58 UTERINE HAEMORRHAGE 1 0.0002
59 HEPATIC PAIN 1 0.0002
60 ABDOMINAL DISCOMFORT 39 0.0002
61 HORDEOLUM 1 0.0002
62 CHAPPED LIPS 1 0.0002
63 MELANOCYTIC NAEVUS 1 0.0002
64 DIARRHOEA 142 0.0002
65 URINE ABNORMALITY 1 0.0002
66 RENAL FUNCTION TEST ABNORMAL 1 0.0002
67 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
68 GASTROINTESTINAL TOXICITY 1 0.0002
69 INCORRECT DOSAGE ADMINISTERED 1 0.0002
70 HOSPICE CARE 2 0.0002
71 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
72 VULVOVAGINAL PRURITUS 1 0.0002
73 PHLEBITIS 1 0.0002
74 INCREASED UPPER AIRWAY SECRETION 1 0.0002
75 PRODUCT USE IN UNAPPROVED INDICATION 47 0.0002
76 LIVER FUNCTION TEST INCREASED 4 0.0002
77 PRODUCT SIZE ISSUE 1 0.0002
78 CHEILITIS 1 0.0002
79 HEPATOTOXICITY 4 0.0002
80 OCULAR DISCOMFORT 2 0.0002
81 MOUTH SWELLING 1 0.0002
82 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
83 VULVOVAGINAL BURNING SENSATION 1 0.0002
84 DYSPEPSIA 16 0.0002
85 LARYNGEAL OEDEMA 1 0.0002
86 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
87 SINUS CONGESTION 2 0.0001
88 THROAT TIGHTNESS 4 0.0001
89 EPISTAXIS 11 0.0001
90 ECCHYMOSIS 1 0.0001
91 DUODENAL ULCER 1 0.0001
92 BLINDNESS TRANSIENT 1 0.0001
93 IMMUNODEFICIENCY 2 0.0001
94 NAUSEA 105 0.0001
95 TENDON PAIN 1 0.0001
96 PRODUCT USE COMPLAINT 2 0.0001
97 BLOOD POTASSIUM INCREASED 2 0.0001
98 ABNORMAL FAECES 1 0.0001
99 CHOLELITHIASIS 4 0.0001
100 HEPATITIS 3 0.0001
101 PYELONEPHRITIS 1 0.0001
102 GASTROINTESTINAL DISORDER 10 0.0001
103 GOUT 2 0.0001
104 ANAL INCONTINENCE 1 0.0001
105 HEAVY MENSTRUAL BLEEDING 1 0.0001
106 BLOOD BILIRUBIN INCREASED 3 0.0001
107 INCREASED TENDENCY TO BRUISE 1 0.0001
108 DIARRHOEA HAEMORRHAGIC 1 0.0001
109 ARTERIOSCLEROSIS 1 0.0001
110 CONTUSION 10 0.0001
111 DIZZINESS POSTURAL 1 0.0001
112 AUTOIMMUNE DISORDER 1 0.0001
113 VITAMIN D DEFICIENCY 1 0.0001
114 LABORATORY TEST ABNORMAL 3 0.0001
115 DRY THROAT 1 0.0001
116 DRUG LEVEL DECREASED 1 0.0001
117 SLUGGISHNESS 1 0.0001
118 TRANSFUSION 1 0.0001
119 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
120 SCRATCH 1 0.0001
121 INCONTINENCE 1 0.0001
122 FULL BLOOD COUNT ABNORMAL 1 0.0001
123 ABDOMINAL PAIN UPPER 19 0.0001
124 BLOOD GLUCOSE FLUCTUATION 1 0.0001
125 SKIN INFECTION 1 0.0001
126 EYE INFECTION 1 0.0001
127 FLATULENCE 5 0.0001
128 MICTURITION URGENCY 1 0.0001
129 INTERNAL HAEMORRHAGE 1 0.0001
130 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
131 BLOOD IRON DECREASED 1 0.0001
132 HEADACHE 52 0.0001
133 URINARY TRACT INFECTION 14 0.0001
134 CYTOPENIA 1 0.0001
135 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
136 ILEUS 1 0.0001
137 INTENTIONAL PRODUCT MISUSE 7 0.0001
138 INTRAOCULAR PRESSURE INCREASED 1 0.0001
139 PLATELET COUNT INCREASED 1 0.0001
140 TOOTH INFECTION 1 0.0001
141 GINGIVAL BLEEDING 1 0.0001
142 APHONIA 1 0.0001
143 WOUND 2 0.0001
144 DRUG INEFFECTIVE 92 0.0001
145 MYELODYSPLASTIC SYNDROME 1 0.0001
146 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
147 SKIN HAEMORRHAGE 1 0.0001
148 PULMONARY MASS 1 0.0001
149 THROAT IRRITATION 3 0.0001
150 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
151 LACRIMATION INCREASED 2 0.0001
152 STOMATITIS 4 0.0001
153 VISION BLURRED 9 0.0001
154 ABDOMINAL PAIN 15 0.0001
155 RENAL DISORDER 3 0.0001
156 FATIGUE 50 0.0001
157 BRAIN FOG 1 0.0001
158 OCULAR HYPERAEMIA 3 0.0001
159 RESPIRATORY TRACT CONGESTION 1 0.0001
160 PRODUCTIVE COUGH 3 0.0001
161 RHINORRHOEA 4 0.0001
162 VOMITING 29 0.0001
163 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
164 FUNGAL INFECTION 2 0.0001
165 MYALGIA 10 0.0001
166 HEPATIC ENZYME INCREASED 4 0.0001
167 ASTHENIA 21 0.0001
168 LEUKOCYTOSIS 1 0.0001
169 CONSTIPATION 12 0.0001
170 TREATMENT NONCOMPLIANCE 3 0.0001
171 HEPATIC STEATOSIS 1 0.0001
172 EYE PAIN 3 0.0001
173 FEELING JITTERY 1 0.0001
174 INCREASED APPETITE 1 0.0001
175 ERUCTATION 1 0.0001
176 DYSPHONIA 3 0.0001
177 ORAL HERPES 1 0.0001
178 NASAL CONGESTION 3 0.0001
179 KIDNEY INFECTION 1 0.0001
180 ARTHRALGIA 21 0.0001
181 SINUS DISORDER 1 0.0001
182 PRESCRIBED UNDERDOSE 1 0.0001
183 FULL BLOOD COUNT DECREASED 1 0.0000
184 THERAPEUTIC RESPONSE DECREASED 3 0.0000
185 FEEDING DISORDER 1 0.0000
186 DRY MOUTH 4 0.0000
187 BODY TEMPERATURE INCREASED 1 0.0000
188 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
189 ROAD TRAFFIC ACCIDENT 2 0.0000
190 FAECES DISCOLOURED 1 0.0000
191 DIZZINESS 23 0.0000
192 PRODUCT PRESCRIBING ISSUE 1 0.0000
193 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
194 PULMONARY OEDEMA 2 0.0000
195 ORAL PAIN 1 0.0000
196 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
197 THERAPY NON-RESPONDER 2 0.0000
198 CHROMATURIA 1 0.0000
199 DYSPHAGIA 4 0.0000
200 DYSGEUSIA 3 0.0000
201 PNEUMONIA ASPIRATION 1 0.0000
202 ABDOMINAL PAIN LOWER 1 0.0000
203 MUSCULOSKELETAL PAIN 2 0.0000
204 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
205 EAR INFECTION 1 0.0000
206 FREQUENT BOWEL MOVEMENTS 1 0.0000
207 DIVERTICULITIS 1 0.0000
208 INFLUENZA 4 0.0000
209 RED BLOOD CELL COUNT DECREASED 1 0.0000
210 LIVER FUNCTION TEST ABNORMAL 1 0.0000
211 DYSSTASIA 1 0.0000
212 BONE PAIN 2 0.0000
213 DISEASE PROGRESSION 4 0.0000
214 APHASIA 1 0.0000
215 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
216 DISCOMFORT 2 0.0000
217 FEELING HOT 2 0.0000
218 NASOPHARYNGITIS 6 0.0000
219 OROPHARYNGEAL PAIN 3 0.0000
220 LIMB DISCOMFORT 1 0.0000
221 MIGRAINE 3 0.0000
222 NIGHT SWEATS 1 0.0000
223 IMPAIRED HEALING 1 0.0000
224 DECREASED APPETITE 7 0.0000
225 LIP SWELLING 1 0.0000
226 DEHYDRATION 4 0.0000
227 SKIN DISORDER 1 0.0000
228 SINUSITIS 3 0.0000
229 HAEMATURIA 1 0.0000
230 ABDOMINAL DISTENSION 3 0.0000
231 RASH MACULAR 1 0.0000
232 LYMPHADENOPATHY 1 0.0000
233 MOBILITY DECREASED 2 0.0000
234 CRYING 1 0.0000
235 PANIC ATTACK 1 0.0000
236 DYSURIA 1 0.0000
237 BRONCHITIS 2 0.0000
238 EYE SWELLING 1 0.0000
239 HEPATIC FUNCTION ABNORMAL 1 0.0000
240 DYSPNOEA EXERTIONAL 1 0.0000
241 INSOMNIA 7 0.0000
242 BLOOD PRESSURE INCREASED 4 0.0000
243 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
244 HOSPITALISATION 4 0.0000
245 PRURITUS 10 0.0000
246 PLASMA CELL MYELOMA 1 0.0000
247 ARTHRITIS 2 0.0000
248 COUGH 7 0.0000
249 NEUTROPHIL COUNT DECREASED 1 0.0000
250 TREATMENT FAILURE 2 0.0000
251 TREMOR 4 0.0000
252 PAIN IN EXTREMITY 7 0.0000
253 PYREXIA 8 0.0000
254 RASH 10 0.0000
255 MUSCULOSKELETAL STIFFNESS 2 0.0000
256 LIVER DISORDER 1 0.0000
257 DRY SKIN 3 0.0000
258 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
259 NEUTROPENIA 3 0.0000
260 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
261 PNEUMONIA 7 0.0000
262 BACK PAIN 5 0.0000
263 BLOOD CHOLESTEROL INCREASED 1 0.0000
264 BLOOD GLUCOSE INCREASED 4 0.0000
265 PAIN 13 0.0000
266 GAIT DISTURBANCE 4 0.0000
267 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
268 DRUG INTOLERANCE 2 0.0000
269 ATRIAL FIBRILLATION 2 0.0000
270 ALOPECIA 4 0.0000
271 CONDITION AGGRAVATED 6 0.0000
272 FLUID RETENTION 1 0.0000
273 CHEST DISCOMFORT 2 0.0000
274 ECZEMA 1 0.0000
275 PARAESTHESIA 3 0.0000
276 DEPRESSED MOOD 1 0.0000
277 DRUG INTERACTION 3 0.0000
278 CONFUSIONAL STATE 3 0.0000
279 RASH PRURITIC 1 0.0000
280 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
281 OFF LABEL USE 16 0.0000
282 FALL 6 0.0000
283 NECK PAIN 1 0.0000
284 OXYGEN SATURATION DECREASED 1 0.0000
285 INCORRECT DOSE ADMINISTERED 4 0.0000
286 LETHARGY 1 0.0000
287 EYE IRRITATION 1 0.0000
288 PALPITATIONS 2 0.0000
289 WHEEZING 1 0.0000
290 CATARACT 1 0.0000
291 JOINT SWELLING 2 0.0000
292 VERTIGO 1 0.0000
293 VISUAL IMPAIRMENT 2 0.0000
294 AMNESIA 1 0.0000
295 SWELLING FACE 1 0.0000
296 BLOOD CREATININE INCREASED 1 0.0000
297 BLOOD PRESSURE DECREASED 1 0.0000
298 NEOPLASM MALIGNANT 1 0.0000
299 WEIGHT DECREASED 4 0.0000
300 INJURY 1 0.0000
301 SLEEP DISORDER 1 0.0000
302 HYPERTENSION 3 0.0000
303 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
304 THERAPY INTERRUPTED 1 0.0000
305 INFECTION 2 0.0000
306 MALAISE 6 0.0000
307 PRODUCT DOSE OMISSION ISSUE 4 0.0000
308 HYPOAESTHESIA 2 0.0000
309 PERIPHERAL SWELLING 2 0.0000
310 URTICARIA 2 0.0000
311 RENAL IMPAIRMENT 1 0.0000
312 PRODUCT STORAGE ERROR 1 0.0000
313 MUSCLE SPASMS 2 0.0000
314 HYPERSENSITIVITY 2 0.0000
315 CARDIAC DISORDER 1 0.0000
316 SWELLING 1 0.0000
317 ANXIETY 3 0.0000
318 NEUROPATHY PERIPHERAL 1 0.0000
319 ANAEMIA 2 0.0000
320 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
321 FLUSHING 1 0.0000
322 HAEMOGLOBIN DECREASED 1 0.0000
323 ILLNESS 1 0.0000
324 HAEMORRHAGE 1 0.0000
325 SEPSIS 1 0.0000
326 THROMBOCYTOPENIA 1 0.0000
327 DYSPNOEA 5 0.0000
328 MUSCULAR WEAKNESS 1 0.0000
329 SEIZURE 1 0.0000
330 CHILLS 1 0.0000
331 OEDEMA PERIPHERAL 1 0.0000
332 HYPERHIDROSIS 1 0.0000
333 MEMORY IMPAIRMENT 1 0.0000
334 CEREBROVASCULAR ACCIDENT 1 0.0000
335 COVID-19 1 0.0000
336 NO ADVERSE EVENT 1 0.0000
337 HYPOTENSION 1 0.0000
338 SOMNOLENCE 1 0.0000
339 ERYTHEMA 1 0.0000
340 WEIGHT INCREASED 1 0.0000
341 DEPRESSION 1 0.0000
342 FEELING ABNORMAL 1 0.0000
343 DEATH 2 0.0000